Overview

Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystec

Status:
Recruiting

Trial end date:
2024-11-01

Target enrollment:

Participant gender:

Summary

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)

Phase:

Phase 3

Details

Lead Sponsor:

Krankenhaus Nordwest

Collaborator:

German Research Foundation

Treatments:

Cisplatin
Gemcitabine